marzo 2022 - Lung Cancer Research Foundation

Search for:

Enter your search term above.

About
Get Involved
Resources
Research
News

Link back to homepage

Link back to homepage

About
Get Involved
Resources
Research
News

In Memoriam
Subscribe
Give Now

Monthly Archives: marzo 2022

Home / News / marzo 2022

Refine Your Search

Categories

Categories

#fdaapprovals #inthenews #sciencemadesimple #womeninlungcancer ALK ASCO chicago clinical trials COVID-19 disparities education EGFR elliots legacy espanol Evening of Innovation free to breathe gala golf Grants iaslc immunotherapy kansas city kites KRAS LCMC LCRF Together marathon memorial News Research science update SCLC survivors symposium targeted therapies tcs nyc marathon team lcrf togetherchicago togetherseparately ttlc Views walk wclc white ribbon yourway

Archives

Executive Director Update | marzo 30, 2022

marzo 30, 2022

Executive Director Update | marzo 30, 2022

Posted in Executive Director Updates

Lung Cancer and KRAS: Behind the Scenes in Research

marzo 29, 2022

Posted in Partnerships, Research, Women & Lung CancerTagged KRAS

LCRF and ALK Positive announce research partnership

marzo 28, 2022

LCRF and ALK Positive announce research partnership

Posted in Announcements, PartnershipsTagged Research

Team LCRF does the United Airlines NYC Half!

marzo 24, 2022

Team LCRF does the United Airlines NYC Half!

Posted in FundraisingTagged team lcrf

Possible new immunotherapy resistance mechanism identified

Possible new immunotherapy resistance mechanism identified

Posted in In the News, ResearchTagged #goodnews, #inthenews

#TogetherSeparately: IASLC targeted therapies recap

marzo 23, 2022

#TogetherSeparately: IASLC targeted therapies recap

Posted in #TogetherSeparatelyTagged togetherseparately

LCRF announces 2022 Request for Proposals

marzo 10, 2022

LCRF announces 2022 Request for Proposals

Posted in Announcements, Research

FDA approves nivolumab with chemotherapy as neoadjuvant treatment for certain patients with resectable NSCLC

marzo 7, 2022

FDA approves nivolumab with chemotherapy as neoadjuvant treatment for certain patients with resectable NSCLC

Posted in FDA News, ResearchTagged #fdaapprovals, Research

LCRF and EGFR Resisters announce request for abstracts

LCRF and EGFR Resisters announce request for abstracts

Posted in Announcements, Grants

LCRF grantee publishes piece on equity in lung cancer screening

marzo 2, 2022

LCRF grantee publishes piece on equity in lung cancer screening

Posted in Disparities, Research, Women & Lung CancerTagged #womeninlungcancer, Research

Subscribe to our mailing list

PO Box 780990 | Philadelphia, PA 19178-0990 | info@LCRF.org Contact Us

Lung Cancer Support Line (844) 835-4325 toll-free

Web Design by Speak Creative. Sitemap

LCRF® is a 501(c)(3) public charity. Federal Tax ID #14-1935776

Español English